Amprius Technologies (NYSE:AMPX) Stock Rating Reaffirmed as Buy by HC Wainwright

Amprius Technologies (NYSE:AMPX)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued to clients and investors on Tuesday, Marketbeat reports. They presently have a $18.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 88.98% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a report on Friday, July 17th. Zacks Research raised Amprius Technologies from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. JonesTrading began coverage on Amprius Technologies in a research report on Friday, July 10th. They set a “buy” rating and a $30.00 price objective for the company. Finally, Clear Str assumed coverage on Amprius Technologies in a report on Tuesday, June 2nd. They issued a “strong-buy” rating and a $33.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.09.

Amprius Technologies Stock Down 0.8%

NYSE AMPX traded down $0.08 during trading on Tuesday, hitting $9.53. The stock had a trading volume of 4,042,450 shares, compared to its average volume of 7,754,291. Amprius Technologies has a twelve month low of $7.71 and a twelve month high of $24.23. The firm has a 50 day moving average price of $10.19 and a 200 day moving average price of $14.49. The company has a market capitalization of $1.35 billion, a PE ratio of -32.84 and a beta of 2.33.

Insider Activity at Amprius Technologies

In related news, CEO Thomas M. Stepien sold 23,529 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $10.34, for a total value of $243,289.86. Following the sale, the chief executive officer owned 602,096 shares of the company’s stock, valued at approximately $6,225,672.64. This represents a 3.76% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kang Sun sold 62,101 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $10.34, for a total value of $642,124.34. Following the completion of the transaction, the director owned 1,218,397 shares of the company’s stock, valued at $12,598,224.98. This trade represents a 4.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 123,311 shares of company stock valued at $1,272,556 in the last ninety days. Corporate insiders own 5.10% of the company’s stock.

Institutional Investors Weigh In On Amprius Technologies

Several hedge funds have recently modified their holdings of AMPX. Wellington Management Group LLP bought a new position in Amprius Technologies during the 2nd quarter worth approximately $4,751,000. Mangrove Partners IM LLC bought a new stake in shares of Amprius Technologies in the 4th quarter valued at approximately $920,000. Calamos Advisors LLC raised its position in shares of Amprius Technologies by 206.2% during the 1st quarter. Calamos Advisors LLC now owns 364,506 shares of the company’s stock valued at $6,146,000 after acquiring an additional 245,473 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new position in Amprius Technologies during the first quarter worth $2,769,000. Finally, SG Americas Securities LLC boosted its holdings in Amprius Technologies by 65.7% in the first quarter. SG Americas Securities LLC now owns 423,037 shares of the company’s stock worth $7,132,000 after purchasing an additional 167,785 shares during the period. 5.04% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Amprius was awarded a grant of up to $75 million through the U.S. Department of War’s Industrial Base Analysis and Sustainment program. The funding will help retrofit an existing domestic EV-battery production line to manufacture high-energy-density cells for unmanned aerial systems, strengthening Amprius’ position as a potential U.S. defense supplier. Amprius Secures $75 Million Grant for American High-Energy Density Battery Production
• Positive Sentiment: The project is expected to support production for Group 1–3 drones and could ultimately reach approximately 12 million cells annually. Because the grant helps fund capacity expansion and reduces the need for Amprius to bear the full capital cost, investors view it as reducing financing, demand and domestic-manufacturing risks while improving the company’s long-term growth prospects. U.S. Awards Amprius Up to $75 Million to Expand Domestic Drone Battery Production
• Positive Sentiment: H.C. Wainwright reaffirmed its Buy rating and set an $18 price target, indicating substantial potential appreciation from recent trading levels. The target reinforces the bullish interpretation of the defense award and Amprius’ expected battery-market growth. H.C. Wainwright Reiterates Buy Rating on Amprius Technologies
• Neutral Sentiment: Grant proceeds are tied to milestones, including facility conversion, partner contributions, NDAA compliance, startup and production ramp-up. The award is therefore an important validation but is not an immediate, unrestricted cash infusion.
• Negative Sentiment: The principal risk is execution. Amprius must scale production through a contract-manufacturing partner and meet defense certifications and delivery requirements. Delays, cost overruns or weaker-than-expected commercialization could limit the benefit of the grant and keep pressure on the shares.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) develops and manufactures high-performance lithium-ion batteries designed to deliver greater energy density and power than conventional lithium-ion batteries. Its technology uses silicon nanowire anodes in place of traditional graphite anodes, enabling batteries with increased energy storage potential while supporting demanding weight and performance requirements.

The company’s battery products are designed for applications including electric aviation, unmanned aerial systems, aerospace, defense, electric mobility and other specialized markets.